- E22.0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM E22.0 became effective on October 1, 2022.
- This is the American ICD-10-CM version of E22.0 – other international versions of ICD-10 E22.0 may differ.
ICD-10-CM E22.0 is grouped within Diagnostic Related Group(s):
- 643 Endocrine disorders with mcc
- 644 Endocrine disorders with cc
- 645 Endocrine disorders without cc/mcc
Applicable To
- Overproduction of growth hormone
Type 1 Excludes
- constitutional gigantism (E34.4)
- constitutional tall stature (E34.4)
- increased secretion from endocrine pancreas of growth hormone-releasing hormone (E16.8)
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to E22.0:
- due to or associated with > Arthritis, arthritic (acute) (chronic) (nonpyogenic) (subacute) M19.90
- acromegaly > due to or associated with E22.0
- in (due to) > Arthritis, arthritic (acute) (chronic) (nonpyogenic) (subacute) M19.90
- acromegaly > in (due to) E22.0
- in (due to) > Arthropathy M12.9
- acromegaly > in (due to) E22.0
- growth > hormone (s) E27.0
- gigantism > Hypophyseal, hypophysis
- disease or syndrome (acromegaly) > Marie\’s
- growth hormone > Overproduction
- gigantism > cerebral
- costovertebral > Syndrome
- Erdheim\’s > Syndrome
- Launois\’ > Syndrome
- Marie\’s (acromegaly) > Syndrome
- pituitary > Syndrome
- Scaglietti-Dagnini > Syndrome